Model ENDORET PRGF - Platelet-Rich Plasma (PRP) Technology
Endoret® (PRGF®) is a platelet-rich plasma (PRP) technology for obtaining autologous proteins from the patient’s own blood. BTI Biotechnology Institute: BTI is considered a worldwide scientific reference in regenerative medicine. This recognition is the result of the successful use of Endoret® (PRGF®) in different medical specialties such as dentistry, traumatology, dermatology, ophthalmology, sports medicine, vascular surgery, aesthetics, among others. Endoret® PRGF® is a closed system, with the necessary equipment and unitary and disposable kits certified for such use that allows a rapid preparation of plasma under sterile conditions and its immediate application.
What is the difference between the closed and the open technique?
- Closed technique:
- Utilizes disposable, single-use kits; the instructions given by the manufacturer of each system must be followed without it being necessary to obtain a certificate of adequacy from the facilities.
- Open technique:
- The method for obtaining PRP should be evaluated and authorised by an inspection by the competent health regulation to verify the suitability of the facilities and the production activities.
Autologous and rich in Growth Factors
- Taken from patient’s blood, so there is less possibility of side effects
- It promotes homeostasis
- Stimulates cell proliferation and migration
- It stimulates the endogenous secretion of proteins from the extracellular matrix
- Platelet concentration compared to baseline between 2 and 3 times
- Balance between growth factors:
- Platelet-based (released by platelets)
- Plasma-based (present free in plasma)
- Process includes elimination of leukocytes, Complement C and IgE
- Preserves the integrity of the fibrin matrix over time
- Promotes the release of growth factors from platelet
- Induces polymerisation of the fibrin matrix
- Technology endorsed by more than 200 indexed scientific publications